6-{4-{4-[2-(4-Methoxyphenyl)phenyl]piperazin-1-yl}butoxy}-2-methyl-2H-benzo[b][1,4]oxazin-3(4H)-one

ID: ALA4799274

PubChem CID: 162676611

Max Phase: Preclinical

Molecular Formula: C30H35N3O4

Molecular Weight: 501.63

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(-c2ccccc2N2CCN(CCCCOc3ccc4c(c3)NC(=O)C(C)O4)CC2)cc1

Standard InChI:  InChI=1S/C30H35N3O4/c1-22-30(34)31-27-21-25(13-14-29(27)37-22)36-20-6-5-15-32-16-18-33(19-17-32)28-8-4-3-7-26(28)23-9-11-24(35-2)12-10-23/h3-4,7-14,21-22H,5-6,15-20H2,1-2H3,(H,31,34)

Standard InChI Key:  YWHVBZKUIRBJHI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 41  0  0  0  0  0  0  0  0999 V2000
   28.2123   -1.6880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2112   -2.5075    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9192   -2.9165    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6289   -2.5071    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6260   -1.6844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9174   -1.2791    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9209   -3.7315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2115   -4.1393    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.2109   -4.9558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9191   -5.3654    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6292   -4.9525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.6263   -4.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.9199   -6.1825    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   27.5031   -2.9156    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.7958   -2.5064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.5025   -3.7328    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.7945   -4.1408    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0871   -3.7316    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.3790   -4.1397    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.0877   -2.9145    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.6717   -3.7305    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.9636   -4.1386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.2562   -3.7294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.5482   -4.1374    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.8408   -3.7283    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8438   -2.9114    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1372   -2.5023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.1373   -4.1372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4302   -3.7319    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4310   -2.9112    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7247   -2.5025    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.0130   -2.9098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.0122   -3.7304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.7230   -4.1437    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.3062   -2.4995    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.3036   -4.1376    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.2127   -6.5919    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
  3  7  1  0
 10 13  1  0
  2 14  1  0
 14 15  1  0
 14 16  1  0
 16 17  1  0
 15 20  1  0
 17 18  1  0
 18 19  1  0
 18 20  1  0
 19 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 30  2  0
 29 28  2  0
 28 25  1  0
 29 30  1  0
 29 34  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 32 35  1  0
 33 36  2  0
 13 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4799274

    ---

Associated Targets(Human)

HTR7 Tclin Serotonin 7 (5-HT7) receptor (5576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALB Tchem Serum albumin (2651 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SCN5A Tclin Sodium channel protein type V alpha subunit (3462 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Htr7 Serotonin 7 (5-HT7) receptor (19 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Mus musculus (284745 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 501.63Molecular Weight (Monoisotopic): 501.2628AlogP: 5.06#Rotatable Bonds: 9
Polar Surface Area: 63.27Molecular Species: BASEHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 11.34CX Basic pKa: 8.51CX LogP: 4.99CX LogD: 3.85
Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.41Np Likeness Score: -0.74

References

1. Lacivita E,Niso M,Stama ML,Arzuaga A,Altamura C,Costa L,Desaphy JF,Ragozzino ME,Ciranna L,Leopoldo M.  (2020)  Privileged scaffold-based design to identify a novel drug-like 5-HT receptor-preferring agonist to target Fragile X syndrome.,  199  [PMID:32442850] [10.1016/j.ejmech.2020.112395]

Source